Marcos G. Joppert, MD

Articles by Marcos G. Joppert, MD

Topoisomerase I-Based Nonplatinum Combinations in Non-Small-Cell Lung Cancer

ByCaio Max S. Rocha Lima, MD,Marcos G. Joppert, MD

September 2nd 2002

Lung cancer is the leading cause of cancer-related death in males and females in the United States. Most patients have advanced disease at diagnosis. Chemotherapy is the treatment of choice for patients with good performance

Latest Updated Articles

Topoisomerase I-Based Nonplatinum Combinations in Non-Small-Cell Lung Cancer
September 2nd 2002

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)